An Economic Evaluation of Government-Funded COVID-19 Testing in Australia.
Jonathan KarnonHossein Haji Ali AfzaliBillie BonevskiPublished in: Applied health economics and health policy (2022)
Our interpretation of the modelled analysis is that at the time of writing (July 2022), with high vaccination uptake in Australia and few other public health measures in place, Australian governments should consider reducing funding of PCR testing, for example, limiting capacity to essential workers and individuals with known risk factors for serious symptoms, and fund RATs for all.